"Targeting Translation Inhibition as a Therapy for Triple Negative Breast Cancer"

CPB Seminar Speaker: Dr. Sanjay Malhotra, OHSU

February 1, 2022
12 p.m. to 1 p.m.


Contact Information
Alanna Hower
Sanjay V. Malhotra, PhD, FRSC

Dr. Malhotra is a Professor & Sheila Edwards-Lienhart Chair in Cancer Research in the Department of Cell Development and Cancer Biology. Also, he is Director, Center for Experimental Therapeutics at the Knight Cancer Institute, OHSU. Before joining OHSU in July 2020, he was a faculty member in the departments of Radiation Oncology (Cancer and Radiation Biology), Radiology (Molecular Imaging Program) and Medicine, at the Stanford University School of Medicine. Dr. Malhotra also served as the Director, Stanford-SRI Drug Discovery and Development Program of the Stanford Cancer Institute. Previously, Dr. Malhotra was ‘Principal Investigator and Head’ of the ‘Small Molecule Drug Discovery Laboratory’ at the National Cancer Institute (NCI), NIH, and served as the Director, Chemical Diversity Division of the Chemical Biology Consortium/NCI. He has over 20 years of experience in basic and translational research. His interests focus on the design and discovery of synthetic and natural product inspired small molecules as probes to understand biological phenomena, and translational research in drug discovery, development, imaging and radiation. Dr. Malhotra’s work has led to preclinical and clinical advancement of several molecules. He has edited five books and authored over 150 research articles, and is an inventor on 15 patent applications. Dr. Malhotra is a Fulbright Specialist and Fellow of the Royal Society of Chemistry, UK.

Speaker seminar flyer